Updated approach for the assessment of ventilator-associated pneumonia

Critical Care Medicine

Volumn 41, Issue 11, 2013, Pages 2641-2642

  Macht, Madison ^a   Robinson, Jeffrey C ^a   Graham, Brian B ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Guidelines; Surveillance; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; CLINICAL ASSESSMENT; EARLY DIAGNOSIS; EDITORIAL; GAS CHROMATOGRAPHY; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HOSPITAL INFECTION; HUMAN; LUNG LAVAGE; MOLECULAR DIAGNOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPPURATION; THORAX RADIOGRAPHY; VENTILATOR ASSOCIATED PNEUMONIA;

ALGORITHMS; HUMANS; INTENSIVE CARE UNITS; POPULATION SURVEILLANCE; RESPIRATION, ARTIFICIAL; VENTILATOR-INDUCED LUNG INJURY;

EID: 84887031250     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182a84be1     Document Type: Editorial

References (14)

1. Klompas M: Does this patient have ventilator-associated pneumonia? JAMA 2007; 297:1583-1593
2. Klompas M: Interobserver variability in ventilator-associated pneumonia surveillance. Am J Infect Control 2010; 38:237-239
3. Skrupky LP, McConnell K, Dallas J, et al: A comparison of ventilator- associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med 2012; 40:281-284
4. Wunderink RG: Radiologic diagnosis of ventilator-associated pneumonia. Chest 2000; 117:188S-190S
5. Morris AC, Kefala K, Simpson AJ, et al: Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia. Thorax 2009; 64:516-522
6. Wunderink RG: Ventilator-associated tracheobronchitis: Publicreporting scam or important clinical infection? Chest 2011; 139:485-488
7. Magill SS, Klompas M, Balk R, et al: Developing a New, National Approach to Surveillance for Ventilator-Associated Events. Crit Care Med 2013; 41:2467-2475
8. Iregui M, Ward S, Sherman G, et al: Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002; 122:262-268
9. Singh N, Rogers P, Atwood CW, et al: Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-511
10. American Thoracic Society, Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416
11. Anand NJ, Zuick S, Klesney-Tait J, et al: Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009; 135:641-647
12. Luyt CE, Combes A, Reynaud C, et al: Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34:1434-1440
13. Lung M, Codina G: Molecular diagnosis in HAP/VAP. Curr Opin Crit Care 2012; 18:487-494
14. Filipiak W, Sponring A, Baur MM, et al: Molecular analysis of volatile metabolites released specifically by Staphylococcus aureus and Pseudomonas aeruginosa. BMC Microbiol 2012; 12:113